S. Jarmin, H. Kymalainen, L. Popplewell, and G. Dickson, New developments in the use of gene therapy to treat Duchenne muscular dystrophy, Expert Opinion on Biological Therapy, vol.60, issue.5, pp.209-230, 2014.
DOI : 10.1002/humu.20918

N. Sharp, J. Kornegay, V. Camp, S. Herbstreith, M. Secore et al., An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy, Genomics, vol.13, issue.1, pp.115-121, 1992.
DOI : 10.1016/0888-7543(92)90210-J

N. Klymiuk, A. Blutke, A. Graf, S. Krause, and K. Burkhardt, Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle, Human Molecular Genetics, vol.22, issue.21, pp.4368-4382, 2013.
DOI : 10.1093/hmg/ddt287

K. Hollinger, C. Yang, R. Montz, D. Nonneman, and J. Ross, Dystrophin insufficiency causes selective muscle histopathology and loss of dystrophin-glycoprotein complex assembly in pig skeletal muscle, The FASEB Journal, vol.28, issue.4, pp.1600-1609, 2014.
DOI : 10.1096/fj.13-241141

G. Bulfield, W. Siller, P. Wight, and K. Moore, X chromosome-linked muscular dystrophy (mdx) in the mouse., Proceedings of the National Academy of Sciences, vol.81, issue.4, pp.1189-1192, 1984.
DOI : 10.1073/pnas.81.4.1189

T. Partridge, The mdx mouse model as a surrogate for Duchenne muscular dystrophy, FEBS Journal, vol.22, issue.17, pp.4177-4186, 2013.
DOI : 10.1111/febs.12267

A. Nakamura and S. Takeda, Mammalian Models of Duchenne Muscular Dystrophy: Pathological Characteristics and Therapeutic Applications, Journal of Biomedicine and Biotechnology, vol.135, issue.5, p.184393, 2011.
DOI : 10.1016/0960-8966(94)90082-5

H. Jacob and A. Kwitek, MULTIFACTORIAL GENETICSRAT GENETICS: ATTACHING PHYSIOLOGY AND PHARMACOLOGY TO THE GENOME, Nature Reviews Genetics, vol.3, issue.1, pp.33-42, 2002.
DOI : 10.1038/nrg702

S. Ménoret, S. Fontanière, D. Jantz, L. Tesson, and R. Thinard, Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases, The FASEB Journal, vol.27, issue.2, pp.703-711, 2013.
DOI : 10.1096/fj.12-219907

A. Geurts, G. Cost, Y. Freyvert, B. Zeitler, and J. Miller, Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases, Science, vol.325, issue.5939, p.433, 2009.
DOI : 10.1126/science.1172447

S. Remy, L. Tesson, S. Menoret, C. Usal, D. Cian et al., Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases, Genome Research, vol.24, issue.8, 2014.
DOI : 10.1101/gr.171538.113

L. Tesson, C. Usal, S. Ménoret, E. Leung, and B. Niles, Knockout rats generated by embryo microinjection of TALENs, Nature Biotechnology, vol.29, issue.8, pp.695-696, 2011.
DOI : 10.1038/nm0310-254

D. Li, Z. Qiu, Y. Shao, Y. Chen, and Y. Guan, Heritable gene targeting in the mouse and rat using a CRISPR-Cas system, Nature Biotechnology, vol.31, issue.8, pp.681-683, 2013.
DOI : 10.1038/oby.2011.81

T. Auer, K. Duroure, D. Cian, A. Concordet, J. et al., Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair, Genome Research, vol.24, issue.1, pp.142-153, 2014.
DOI : 10.1101/gr.161638.113

M. Piganeau, H. Ghezraoui, D. Cian, A. Guittat, L. Tomishima et al., Cancer translocations in human cells induced by zinc finger and TALE nucleases, Genome Research, vol.23, issue.7, pp.1182-1193, 2013.
DOI : 10.1101/gr.147314.112

P. Huang, X. A. Zhou, M. Zhu, Z. Lin, and S. , Heritable gene targeting in zebrafish using customized TALENs, Nature Biotechnology, vol.29, issue.8, pp.699-700, 2011.
DOI : 10.1073/pnas.1013133107

J. Miller, S. Tan, G. Qiao, K. Barlow, and J. Wang, A TALE nuclease architecture for efficient genome editing, Nature Biotechnology, vol.38, issue.2, pp.143-148, 2011.
DOI : 10.1093/nar/30.10.e43

Y. Doyon, T. Vo, M. Mendel, S. Greenberg, and J. Wang, Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures, Nature Methods, vol.649, issue.1, pp.74-79, 2011.
DOI : 10.1016/j.jmb.2010.04.060

E. Fine, T. Cradick, C. Zhao, Y. Lin, and G. Bao, An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage, Nucleic Acids Research, vol.42, issue.6, p.42, 2014.
DOI : 10.1093/nar/gkt1326

A. Geurts, G. Cost, S. Rémy, X. Cui, and L. Tesson, Generation of Gene-Specific Mutated Rats Using Zinc-Finger Nucleases, Methods Mol Biol, vol.597, pp.211-225, 2010.
DOI : 10.1007/978-1-60327-389-3_15

R. Bartlett, S. Stockinger, M. Denis, W. Bartlett, and L. Inverardi, In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide, Nature Biotechnology, vol.86, issue.6, pp.15-622, 2000.
DOI : 10.1038/76448

V. Dubowitz and M. Brooke, Muscle Biopsy: a Modern Approach, pp.335-356, 1985.

M. Carre-pierrat, A. Lafoux, G. Tanniou, L. Chambonnier, and A. Divet, Pre-clinical study of 21 approved drugs in the mdx mouse, Neuromuscular Disorders, vol.21, issue.5, pp.313-327, 2011.
DOI : 10.1016/j.nmd.2011.01.005

D. Luca and A. , Use of grip strength meter to assess the limb strength of mdx mice, 2008.

N. Kanneboyinna, Behavioural and Locomotor Measurements Using Open Field Animal Activity Monitoring System, 2008.

V. Arechavala-gomeza, M. Kinali, L. Feng, M. Guglieri, and G. Edge, Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials, Neuromuscular Disorders, vol.20, issue.5, pp.295-301, 2010.
DOI : 10.1016/j.nmd.2010.03.007

J. Muller, N. Vayssiere, M. Royuela, M. Leger, and A. Muller, Comparative evolution of muscular dystrophy in diaphragm, gastrocnemius and masseter muscles from old male mdx mice, Journal of Muscle Research and Cell Motility, vol.22, issue.2, pp.133-139, 2001.
DOI : 10.1023/A:1010305801236

S. Lin, F. Gaschen, and J. Burgunder, Utrophin Is a Regeneration-associated Protein Transiently Present at the Sarcolemma of Regenerating Skeletal Muscle Fibers in Dystrophin-deficient Hypertrophic Feline Muscular Dystrophy, Journal of Neuropathology & Experimental Neurology, vol.57, issue.8, pp.780-790, 1998.
DOI : 10.1097/00005072-199808000-00007

I. Desguerre, C. Christov, M. Mayer, R. Zeller, and H. Becane, Clinical Heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of Sub-Phenotypes and Predictive Criteria by Long-Term Follow-Up, PLoS ONE, vol.50, issue.2, p.4347, 2009.
DOI : 10.1371/journal.pone.0004347.t005
URL : https://hal.archives-ouvertes.fr/inserm-00447998

E. Hoffman, R. Brown, . Jr, and L. Kunkel, Dystrophin: The protein product of the duchenne muscular dystrophy locus, Cell, vol.51, issue.6, pp.919-928, 1987.
DOI : 10.1016/0092-8674(87)90579-4

M. Koenig, A. Monaco, and L. Kunkel, The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein, Cell, vol.53, issue.2, pp.219-228, 1988.
DOI : 10.1016/0092-8674(88)90383-2

F. Muntoni, S. Torelli, and A. Ferlini, Dystrophin and mutations: one gene, several proteins, multiple phenotypes, The Lancet Neurology, vol.2, issue.12, pp.731-771, 2003.
DOI : 10.1016/S1474-4422(03)00585-4

K. Nowak and K. Davies, Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment, EMBO reports, vol.10, issue.9, pp.872-876, 2004.
DOI : 10.1016/S0960-8966(99)00010-3

W. Klingler, K. Jurkat-rott, F. Lehmann-horn, and R. Schleip, The role of fibrosis in Duchenne muscular dystrophy, Acta Myol, vol.31, pp.184-95, 2012.

N. Whitehead, E. Yeung, and D. Allen, MUSCLE DAMAGE IN MDX (DYSTROPHIC) MICE: ROLE OF CALCIUM AND REACTIVE OXYGEN SPECIES, Clinical and Experimental Pharmacology and Physiology, vol.288, issue.7, pp.657-662, 2006.
DOI : 10.1083/jcb.200105110

D. Allen, O. Gervasio, E. Yeung, and N. Whitehead, Calcium and the damage pathways in muscular dystrophyThis article is one of a selection of papers published in this special issue on Calcium Signaling., Canadian Journal of Physiology and Pharmacology, vol.88, issue.2, pp.83-91, 2010.
DOI : 10.1139/Y09-058

P. Kieny, S. Chollet, P. Delalande, L. Fort, M. Magot et al., Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011, Annals of Physical and Rehabilitation Medicine, vol.56, issue.6, pp.443-454, 1981.
DOI : 10.1016/j.rehab.2013.06.002

K. Nakamura, W. Fujii, M. Tsuboi, J. Tanihata, and N. Teramoto, Generation of muscular dystrophy model rats with a CRISPR, Cas system. Sci Rep, vol.4, pp.5635-56, 2014.

A. Sacco, F. Mourkioti, R. Tran, J. Choi, and M. Llewellyn, Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice, Cell, vol.143, issue.7, pp.1059-1071, 2010.
DOI : 10.1016/j.cell.2010.11.039

F. Mourkioti, J. Kustan, P. Kraft, J. Day, and M. Zhao, Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy, Nature Cell Biology, vol.243, issue.8, pp.895-904, 2013.
DOI : 10.1038/ncb2790